Sivik Global Healthcare LLC reduced its holdings in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 13.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 200,000 shares of the company's stock after selling 30,000 shares during the quarter. Surgery Partners accounts for about 2.2% of Sivik Global Healthcare LLC's investment portfolio, making the stock its 20th largest holding. Sivik Global Healthcare LLC owned about 0.16% of Surgery Partners worth $4,234,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also made changes to their positions in the company. Sei Investments Co. acquired a new position in Surgery Partners in the second quarter worth about $699,000. Mackenzie Financial Corp lifted its holdings in Surgery Partners by 3.4% during the 2nd quarter. Mackenzie Financial Corp now owns 19,999 shares of the company's stock worth $476,000 after buying an additional 662 shares during the last quarter. Quarry LP grew its position in shares of Surgery Partners by 133.1% in the 2nd quarter. Quarry LP now owns 3,082 shares of the company's stock worth $73,000 after acquiring an additional 1,760 shares in the last quarter. Clearbridge Investments LLC increased its holdings in shares of Surgery Partners by 1.3% in the 2nd quarter. Clearbridge Investments LLC now owns 5,585,530 shares of the company's stock valued at $132,880,000 after acquiring an additional 73,007 shares during the last quarter. Finally, Handelsbanken Fonder AB raised its position in shares of Surgery Partners by 35.1% during the 3rd quarter. Handelsbanken Fonder AB now owns 18,100 shares of the company's stock valued at $584,000 after acquiring an additional 4,700 shares in the last quarter.
Surgery Partners Stock Performance
SGRY traded down $0.18 during trading hours on Monday, hitting $25.31. The company's stock had a trading volume of 518,148 shares, compared to its average volume of 1,688,199. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99. Surgery Partners, Inc. has a fifty-two week low of $19.50 and a fifty-two week high of $35.29. The company has a 50-day simple moving average of $21.61 and a 200 day simple moving average of $27.05. The firm has a market capitalization of $3.22 billion, a PE ratio of -52.75, a PEG ratio of 17.66 and a beta of 2.60.
Surgery Partners (NASDAQ:SGRY - Get Free Report) last issued its quarterly earnings data on Tuesday, November 12th. The company reported $0.19 earnings per share for the quarter, missing analysts' consensus estimates of $0.25 by ($0.06). The company had revenue of $770.40 million for the quarter, compared to the consensus estimate of $768.99 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. Surgery Partners's revenue for the quarter was up 14.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.15 earnings per share. As a group, sell-side analysts expect that Surgery Partners, Inc. will post 0.71 EPS for the current year.
Analyst Upgrades and Downgrades
SGRY has been the subject of a number of research reports. JPMorgan Chase & Co. decreased their price objective on shares of Surgery Partners from $38.00 to $28.00 and set a "neutral" rating for the company in a report on Tuesday, December 3rd. Macquarie reaffirmed an "outperform" rating and issued a $34.00 price target on shares of Surgery Partners in a report on Tuesday, November 19th. Bank of America assumed coverage on shares of Surgery Partners in a research note on Monday, December 16th. They set a "buy" rating and a $30.00 price objective on the stock. KeyCorp began coverage on Surgery Partners in a research note on Friday, October 11th. They issued a "sector weight" rating for the company. Finally, UBS Group initiated coverage on Surgery Partners in a research report on Monday, October 14th. They set a "buy" rating and a $38.00 price target on the stock. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $36.56.
Read Our Latest Analysis on Surgery Partners
About Surgery Partners
(
Free Report)
Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
See Also
Before you consider Surgery Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Surgery Partners wasn't on the list.
While Surgery Partners currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
